58.30CHF+0.17%Mkt Cap: —P/E: 44.671d ago
Cosmo N.V., a life sciences company, develops and manufactures pharmaceuticals and contracts for gastroenterology, dermatology, and health tech in Ireland and internationally. The company offers GI Genius, a computer-ass…
Industry Peers
Drug Manufacturers - GeneralKey Statistics
Company
Market Cap—
Enterprise Value906.73M $
Revenue (TTM)117.20M $
Gross Profit53.34M $
Net Income (TTM)-7.25M $
Revenue/Share7.100 USD
Last Price58.30 CHF
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees365
CountryGB
SectorHealthcare
IndustryDrug Manufacturers - General
ISINNL0011832936
Valuation
P/E (Trailing)44.67
P/E (Forward)—
PEG—
EV/EBITDA659.86
EV/Revenue7.74
P/S—
P/B1.84
EPS (TTM)1.30
EPS (Forward)—
52W Range
56.8056% of range59.50
52W High59.50 CHF
52W Low56.80 CHF
Profitability
Gross Margin45.51%
Oper. Margin-17.73%
EBITDA Margin1.17%
Profit Margin-6.19%
ROE-1.19%
ROA-1.07%
Growth
Revenue Growth-2.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-23.90M $
CapEx (TTM)—
FCF Margin-26.44%
FCF Yield—
Net Debt-217.26M $
Net Debt/EBITDA-158.11
Balance Sheet
Debt/Equity0.75
Current Ratio10.66
Quick Ratio9.84
Book Value/Sh30.88 CHF
Cash/Share11.32 CHF
Dividends
Fwd Div Rate—
Trail. Div Rate2.100 CHF
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.15.00M
Float9.69M
Insiders51.77%
Institutions18.93%
Technical
SMA 5063.20 (-7.7%)
SMA 20048.12 (+21.1%)
Beta1.48
S&P 52W Chg20.80%
Avg Vol (30d)3.65K
Avg Vol (10d)1.06K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—